Kim, Hyun J. http://orcid.org/0000-0001-7986-7798
Snyder, Laurie D.
Neely, Megan L.
Hellkamp, Anne S.
Hotchkin, David L.
Morrison, Lake D.
Bender, Shaun
Leonard, Thomas B.
Culver, Daniel A.
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
Rationale for and design of the Idiopathic Pulmonary Fibrosis–PRospective Outcomes (IPF-PRO) registry
https://doi.org/10.1136/bmjresp-2015-000108
Clinical Outcomes of Patients with Combined Idiopathic Pulmonary Fibrosis and Emphysema in the IPF-PRO Registry
https://doi.org/10.1007/s00408-021-00506-x
Hospitalizations in patients with idiopathic pulmonary fibrosis
https://doi.org/10.1186/s12931-021-01851-4
Associations between resources and practices of ILD centers and outcomes in patients with idiopathic pulmonary fibrosis: data from the IPF-PRO Registry
https://doi.org/10.1186/s12931-021-01921-7
Time to diagnosis of idiopathic pulmonary fibrosis in the IPF-PRO Registry
https://doi.org/10.1136/bmjresp-2020-000567
Funding for this research was provided by:
The IPF-PRO™ Registry is funded by Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and co-ordinated by the Duke Clinical Research Institute (DCRI).
Article History
Received: 1 September 2021
Accepted: 13 December 2021
First Online: 7 January 2022
Declarations
:
: HJK has no disclosures. LDS, MLN, ASH are employees of the Duke Clinical Research Institute (DCRI), which receives funding support from Boehringer Ingelheim Pharmaceuticals, Inc, to co-ordinate the IPF-PRO/ILD-PRO Registry. DLH reports research fees from Boehringer Ingelheim. LDM reports personal fees from Boehringer Ingelheim and Genentech. SB is an employee of Boehringer Ingelheim Pharmaceuticals, Inc. TBL was an employee of Boehringer Ingelheim Pharmaceuticals, Inc at the time this research was conducted. DAC reports personal fees from Boehringer Ingelheim and Genentech.
: The study was approved by the Duke University Institutional Review Board (Pro00046131). The protocol was also approved by the relevant Institutional Review Boards and/or local Independent Ethics Committees prior to patient enrollment at each site.
: All patients provided informed consent.
: Not applicable.